Metformin is Associated with Decreased 30-Day Mortality Among Nursing Home Residents Infected with SARS-CoV2

OBJECTIVES: The COVID-19 pandemic presents an urgent need to investigate whether existing drugs can enhance or even worsen prognosis; metformin, a known mammalian target of rapamycin (m-TOR) inhibitor, has been identified as a potential agent. We sought to evaluate mortality benefit among older pers...

Descripción completa

Detalles Bibliográficos
Autores principales: Lally, Michelle A., Tsoukas, Philip, Halladay, Christopher W., O'Neill, Emily, Gravenstein, Stefan, Rudolph, James L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586924/
https://www.ncbi.nlm.nih.gov/pubmed/33232684
http://dx.doi.org/10.1016/j.jamda.2020.10.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586924/
https://www.ncbi.nlm.nih.gov/pubmed/33232684
http://dx.doi.org/10.1016/j.jamda.2020.10.031

Ejemplares similares